Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Cambrex has acquired IEP, a Wiesbaden, Germany-based firm that specializes in developing biocatalytic processes and making enzymes for drug companies. “In combination with our existing chiral chemistry business, the acquisition of IEP will result in Cambrex’ being able to offer a broad biocatalysis platform to the pharmaceutical industry,” says Cambrex CEO Steven M. Klosk. Biocatalysis is of growing interest to fine chemicals companies. In 2004, for example, IEP contributed biocatalysis expertise to a chiral chemistry consortium formed by Almac Sciences.
This article has been sent to the following recipient: